Interestingly, COPZ1 knockdown kills both proliferating and non-dividing tumor cells, but does not affect normal cells, thus suggesting that COPZ1-targeting therapies have the potential for eradicating cancer cells, independently of whether they are actively proliferating. Here, COPZ1 is linked to cancer.